Literature DB >> 31537698

Latent tuberculosis screening and treatment among asylum seekers: a mixed-methods study.

Ineke Spruijt1,2, Dawit Tesfay Haile2, Jeanine Suurmond2, Susan van den Hof3,4, Marga Koenders5, Peter Kouw6, Natascha van Noort7, Sophie Toumanian8, Frank Cobelens9, Simone Goosen10, Connie Erkens3.   

Abstract

INTRODUCTION: Evidence on conditions for implementation of latent tuberculosis infection (LTBI) screening and treatment among asylum seekers is needed to inform tuberculosis (TB) control policies. We used mixed-methods to evaluate the implementation of an LTBI screening and treatment programme among asylum seekers in the Netherlands.
METHODS: We offered voluntary LTBI screening to asylum seekers aged ≥12 years living in asylum seeker centres from countries with a TB incidence >200 per 10 000 population. We calculated LTBI screening and treatment cascade coverage, and assessed associated factors with Poisson regression using robust variance estimators. We interviewed TB care staff (seven group interviews) and Eritrean clients (21 group and 21 individual interviews) to identify programme enhancers and barriers.
RESULTS: We screened 719 (63% of 1136) clients for LTBI. LTBI was diagnosed among 178 (25%) clients; 149 (84%) initiated LTBI treatment, of whom 129 (87%) completed treatment. In-person TB and LTBI education, the use of professional interpreters, and collaboration with partner organisations were enhancers for LTBI screening uptake. Demand-driven LTBI treatment support by TB nurses enhanced treatment completion. Factors complicating LTBI screening and treatment were having to travel to public health services, language barriers and moving from asylum seeker centres to the community during treatment.
CONCLUSION: LTBI screening and treatment of asylum seekers is feasible and effective when high quality of care is provided, including culture-sensitive TB education throughout the care cascade. Additionally, collaboration with partner organisations, such as agencies responsible for reception and support of asylum seekers, should be in place.
Copyright ©ERS 2019.

Entities:  

Year:  2019        PMID: 31537698     DOI: 10.1183/13993003.00861-2019

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  5 in total

1.  Strategies to reach and motivate migrant communities at high risk for TB to participate in a latent tuberculosis infection screening program: a community-engaged, mixed methods study among Eritreans.

Authors:  Ineke Spruijt; Dawit Tesfay Haile; Connie Erkens; Susan van den Hof; Simone Goosen; Andrea Ten Kate; Hewan Teshome; Marja Karels; Marga Koenders; Jeanine Suurmond
Journal:  BMC Public Health       Date:  2020-03-12       Impact factor: 3.295

2.  Targeting screening and treatment for latent tuberculosis infection towards asylum seekers from high-incidence countries - a model-based cost-effectiveness analysis.

Authors:  Florian M Marx; Barbara Hauer; Nicolas A Menzies; Walter Haas; Nita Perumal
Journal:  BMC Public Health       Date:  2021-11-26       Impact factor: 4.135

3.  Initiation and completion of treatment for latent tuberculosis infection in migrants globally: a systematic review and meta-analysis.

Authors:  Kieran Rustage; Jessica Lobe; Sally E Hayward; Kristina L Kristensen; Ioana Margineanu; Ymkje Stienstra; Delia Goletti; Dominik Zenner; Teymur Noori; Manish Pareek; Christina Greenaway; Jon S Friedland; Laura B Nellums; Sally Hargreaves
Journal:  Lancet Infect Dis       Date:  2021-08-04       Impact factor: 25.071

4.  Latent Tuberculosis Infection Treatment Completion while Shifting Prescription from Isoniazid-Only to Rifampicin-Containing Regimens: A Two-Decade Experience in Milan, Italy.

Authors:  Simone Villa; Maurizio Ferrarese; Giovanni Sotgiu; Paola Francesca Castellotti; Laura Saderi; Cecilia Grecchi; Matteo Saporiti; Mario Raviglione; Luigi Ruffo Codecasa
Journal:  J Clin Med       Date:  2019-12-31       Impact factor: 4.241

5.  Knowledge, attitudes, beliefs, and stigma related to latent tuberculosis infection: a qualitative study among Eritreans in the Netherlands.

Authors:  Ineke Spruijt; Dawit Tesfay Haile; Susan van den Hof; Kathy Fiekert; Niesje Jansen; Degu Jerene; Eveline Klinkenberg; Ieva Leimane; Jeanine Suurmond
Journal:  BMC Public Health       Date:  2020-10-23       Impact factor: 3.295

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.